P3 Health Partners Stock Investor Sentiment

PIII Stock  USD 0.21  0.01  4.55%   
Under 56% of all P3 Health's traders are looking to take a long position. The analysis of overall sentiment of trading P3 Health Partners stock suggests that some investors are interested at this time. P3 Health's investing sentiment shows overall attitude of investors towards P3 Health Partners.
  

P3 Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards P3 Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at thelincolnianonline.com         
TD Cowen Lowers P3 Health Partners Price Target to 0.25
news
3 days ago at simplywall.st         
Some P3 Health Partners Inc. Analysts Just Made A Major Cut To Next Years Estimates
Simply Wall St News at Macroaxis
3 days ago at finance.yahoo.com         
P3 Health Partners to Participate in Upcoming Investor Conferences
Yahoo News
3 days ago at investing.com         
P3 Health Partners stock target cut, hold rating continued on Q3 results
Investing News at Macroaxis
few days ago at www.macroaxis.com         
Acquisition by Bacchus Amir of 1000000 shares of P3 Health subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Alyeska Investment Group L.P.s Strategic Acquisition in P3 Health Partners Inc.
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Analysts Have Lowered Expectations For P3 Health Partners Inc. After Its Latest Results
Yahoo News
over a week ago at simplywall.st         
P3 Health Partners Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags
Simply Wall St News at Macroaxis
over a week ago at simplywall.st         
P3 Health Partners Inc.s market cap dropped US19m last week Private equity firms bore the brunt
Simply Wall St News at Macroaxis
over a week ago at gurufocus.com         
P3 Health Partners Inc Q3 2024 Earnings Call Highlights Navigating Growth and Challenges
Gurufocus Stories at Macroaxis
over a week ago at insidermonkey.com         
P3 Health Partners Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a week ago at businesswire.com         
P3 Health Partners Announces Third Quarter 2024 Results
businesswire News
over a week ago at gurufocus.com         
P3 Health Partners Inc Reports Q3 Revenue of 362. ...
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
What To Expect From P3 Health Partners Inc Q3 2024 Earnings
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Definitive Healthcare Corp. Beats Q3 Earnings and Revenue Estimates
zacks News
Far too much social signal, news, headlines, and media speculation about P3 Health that are available to investors today. That information is available publicly through PIII media outlets and privately through word of mouth or via PIII internal channels. However, regardless of the origin, that massive amount of PIII data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of P3 Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of P3 Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to P3 Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive P3 Health alpha.

P3 Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4883 subject to Rule 16b-3
09/04/2024
2
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4898 subject to Rule 16b-3
09/06/2024
3
Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.5591 subject to Rule 16b-3
09/11/2024
4
SHAREHOLDER ALERT Levi Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc.
09/23/2024
5
Insider Trading
10/01/2024
6
SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Partners, Inc.
10/10/2024
7
SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
10/14/2024
8
SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partners
10/29/2024
9
Acquisition by Erin Darakjian of 100000 shares of P3 Health subject to Rule 16b-3
11/05/2024
10
What To Expect From P3 Health Partners Inc Q3 2024 Earnings
11/11/2024
11
P3 Health Partners Inc. Q3 2024 Earnings Call Transcript
11/13/2024
12
P3 Health Partners Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags
11/15/2024
13
Acquisition by Bacchus Amir of 1000000 shares of P3 Health subject to Rule 16b-3
11/19/2024
14
TD Cowen Lowers P3 Health Partners Price Target to 0.25
11/21/2024

Complementary Tools for PIII Stock analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum